Business Strategy Astorg Acquires Thermo Fisher Scientific’s Microbiology Business

Source: Press release Thermo Fisher Scientific 0 min Reading Time

Related Vendors

Thermo Fisher Scientific has successfully sold its microbiology business to Astorg for 1.075 billion dollars. The business was part of Thermo Fisher's Specialty Diagnostics segment.

The microbiology business generated 645 million dollars in revenue in 2025 and was part of Thermo Fisher's Specialty Diagnostics segment.(Source:  Thermo Fisher Scientific)
The microbiology business generated 645 million dollars in revenue in 2025 and was part of Thermo Fisher's Specialty Diagnostics segment.
(Source: Thermo Fisher Scientific)

Massachusetts/USA – Thermo Fisher Scientific has recently completed the sale of its microbiology business to Astorg, a leading pan-European private equity firm, for consideration of approximately 1.075 billion dollars, consisting of cash and a 50-million-dollar seller note.

The microbiology business provides antimicrobial susceptibility testing and culture media solutions for clinical, pharmaceutical and food safety testing. The business generated 645 million dollars in revenue in 2025 and was part of Thermo Fisher's Specialty Diagnostics segment.

(ID:50930948)

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy. The consent declaration relates, among other things, to the sending of editorial newsletters by email and to data matching for marketing purposes with selected advertising partners (e.g., LinkedIn, Google, Meta)

Unfold for details of your consent